Avicenna Day 2020

 

Tuesday 25 August 2020

Time: 14.00 – 18:30 CEST / 13.00 - 17.30 BST / 17.30 - 22.00 IST / 8.00 - 12.30 EDT / 7.00 -11.30 CDT

 

 

14:00 – 14:15

Welcome and presentation of the Avicenna Successful Journey

Thierry Marchal, Secretary General, Avicenna Alliance

14:15 – 14:40

Successful use of in silico for regulatory approval

14:15 – 14:25

Medical Device Case study – Steven Levine, Dassault Systèmes

14:25 – 14:35

Pharmaceutical case study – François Boissel, Novadiscovery

14:35 – 14:40

Q&A with the audience moderated by Alicia Waterkeyn (Avicenna Secretariat, RPP group)

14:40 – 15:55

Session I - A policy community

14:40 – 14:55

Mission, achievements and plan

Emmanuelle Voisin, Policy Development Working Group Leader, Voisin Consulting Life Sciences

14:55 – 15:05

Important directions for Europe in 2021 & 2022

James Kennedy, Avicenna Secretariat, RPP Group

15:05 – 15:15

Towards Good Simulation Practice

Luca Emili, Chair of the GSP Taskforce, InsilicoTrials Technologies

15:15 – 15:30

A valuable collaboration with EMA

Liesbet Geris Research and Technology Working Group Leader, VPHi, University of Liège & KU Leuven

Flora Musuamba, European Medicines Agency, Modelling and Simulation Working Party

15:30 – 15:45

Engaging with Notified Bodies

Simon Sonntag, Chair of the Notified Bodies Taskforce, Virtonomy

Françoise Schlemmer, Director, The European Association for Medical devices of Notified Bodies (Team-NB))

15:45 – 15:55

Q&A with the audience moderated by Alicia Waterkeyn, RPP group

15:55 – 16:25

Session II - An international community

15:55 – 16:00

Mission, achievements and plan

Markus Reiterer, International Working Group Leader, Medtronic

16:00 – 16:10

Computer modelling as regulatory evidence at FDA

Brent Craven, U.S. Food and Drug Administration

16:10 – 16:20

Global Recommendations for in silico Evidence

Marc Horner, Ansys

16:20 – 16:25

Q&A with the audience moderated by Alicia Waterkeyn, RPP group

16:25 – 16:40

Break

16:40 – 17:45

Session III - A research & technology community

16:40 – 16:50

Mission, achievements and plan

Liesbet Geris, Research and Technology Working Group Leader, VPHi, University of Liège & KU Leuven

16:50 – 17:05

Certified Materials Library

Venkat Perumal, Chair of the Materials Library Taskforce, Stryker

Nele Famaey, KU Leuven

17:05 – 17:20

Funding for in silico in Horizon Europe projects

Liesbet Geris, VPHi, KU Leuven, ULiege

Nathalie Virag, Medtronic

17:20 – 17:35

The role of AI for in silico medicine

Jérôme Noailly, VPHi, Pompeu Fabra University, Barcelona

Payman Afshari, DePuy Spine, Johnson and Johnson

17:35 – 17:45

Q&A with the audience moderated by Alicia Waterkeyn, RPP group

17:45 – 18:20

Session IV – Interactive Panel Discussion with Avicenna Alliance Board Members

Liesbet Geris, Research and Technology Working Group Leader, VPHi, University of Liège & KU Leuven

Emmanuelle Voisin, Policy Development Working Group Leader, Voisin Consulting Life Science

Markus Reiterer, International Working Group Leader, Medtronic

Luca Emili, Avicenna Treasurer, InsilicoTrials Technologies

James Kennedy, Avicenna Secretariat, RPP Group

Thierry Marchal, Secretary General, Avicenna Alliance

18:20 – 18:30

Concluding Remarks

Thierry Marchal, Secretary General, Avicenna Alliance

Avicenna Alliance news

Avicenna provides feedback to the public consultation on European Medicines Agencies Network Strategy to 2025

On 4 September the Avicenna Alliance provided feedback to the public consultation on...

find out more ›

The Avicenna Alliance organized its first Avicenna Day 2020 on August 25

The Avicenna Alliance organized its first Avicenna Day 2020 online event on Tuesday August 25!

find out more ›

The European Commission published a Draft proposal on the European Partnership for Health Innovation

On 29 July the European Commission published a Draft proposal on the European Partnership for...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up